| CAS: | 5104-49-4 | ||||||||||||||
| 分子式: | C16H13FO2 | ||||||||||||||
| 分子量: | 244.270 | ||||||||||||||
| 熔点: | 110-112°C (Lit.) | ||||||||||||||
| 中文名称: |
| ||||||||||||||
| 英文名称: |
| ||||||||||||||
| 性质描述: | 白色细微结晶粉末。熔点110111℃。易溶于乙醇,乙醚,丙酮,氯护、氯仿等有机溶剂,几乎不溶于水,有刺激性臭味。 | ||||||||||||||
| 生产方法: | 由2-氟联苯乙酮经氧化,酯化,酯交换,水解,脱羧等反应制得。 | ||||||||||||||
| 用途: | 该品为解热镇痛药,用于慢性关节炎,变形关节症的镇痛,消炎,以及拔牙及外科手术后的镇痛。小鼠口服LD50为140mg/kg,大鼠为640-800mg/kg。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| F798106 | MACKLIN | 氟比洛芬 | 10mM in DMSO | 131元/1ml; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| F838235 | MACKLIN | 氟比洛芬 | 98% | 37元/1g; 102元/5g; 467元/25g; 1626元/100g; 7884元/500g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
储存:室温 状态:白色粉末 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| F0371 | TCI | Flurbiprofen | >98.0%(T)(HPLC) | 890元/5G; 2750元/25G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
安全信息
相关法规
运输信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 916054 | J&K | Flurbiprofen | 99%, 非甾体抗炎化合物 | 212元/1G; 846元/5G; 2613元/25G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| B22603 | Alfa Aesar | 2-Fluoro-alpha-methyl-4-biphenylacetic acid | 99% | 1382元/1g; 5157元/5g; 18959元/25g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
应用 基本信息 MDL EINECS 分子式 分子量 熔点 灵敏度 形态 Merck GHS危害和防范说明 GHS符号 Hazard Statements Precautionary Statements 安全信息 危险等级 包装组 危险类别 安全等级 RTECS TSCA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| F8514 | Sigma-Aldrich | Flurbiprofen | cyclooxygenase inhibitor | 1237.7元/1 G; 4635.9元/5 G; 11182.7元/25 G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 应用 Flurbiprofen is a nonsteroidal anti-inflammatory agent (NSAIA) with antipyretic, analgesic, and antifungal activity. Oral formulations of flurbiprofen may be used to treat rheumatoid arthritis, osteoarthritis and anklylosing spondylitis. Flurbiprofen is also used topically during ocular surgery to prevent or reduce intraoperative miosis. Flurbiprofen is structurally and pharmacologically related to ibuprofen. It is used to study the pathophysiological steps of NSAID enteropathy in the rat and the biotransformation of flurbiprofen by Cunninghamella species. 包装 1, 5, 25 g in poly bottle 生化/生理作用 Fluibiprofen is a cyclooxygenase (COX) inhibitor, which is an enzyme responsible for the conversion of arachidonic acid to prostaglandin G2 (PGG2) and PGG2 to prostaglandin H2 (PGH2) in the prostaglandin synthesis pathway. This decreases the prostaglandins which cause inflammation, pain, swelling and fever. Flurbiprofen inhibits the activity of both COX-1 and -2. The S enantiomer inhibits prostaglandin synthesis and has both anti-inflammatory and analgesic activity, while the R enantiomer does not inhibit prostaglandin synthesis and displays only analgesic activity. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| F0285200 | Flurbiprofen | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 Fluibiprofen is a cyclooxygenase (COX) inhibitor, which is an enzyme responsible for the conversion of arachidonic acid to prostaglandin G2 (PGG2) and PGG2 to prostaglandin H2 (PGH2) in the prostaglandin synthesis pathway. This decreases the prostaglandins which cause inflammation, pain, swelling and fever. Flurbiprofen inhibits the activity of both COX-1 and -2. The S enantiomer inhibits prostaglandin synthesis and has both anti-inflammatory and analgesic activity, while the R enantiomer does not inhibit prostaglandin synthesis and displays only analgesic activity. 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0002271 | Flurbiprofen for peak identification | CRS, European Pharmacopoeia (EP) Reference Standard | 1341.2元/ ; | 展开 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 Fluibiprofen is a cyclooxygenase (COX) inhibitor, which is an enzyme responsible for the conversion of arachidonic acid to prostaglandin G2 (PGG2) and PGG2 to prostaglandin H2 (PGH2) in the prostaglandin synthesis pathway. This decreases the prostaglandins which cause inflammation, pain, swelling and fever. Flurbiprofen inhibits the activity of both COX-1 and -2. The S enantiomer inhibits prostaglandin synthesis and has both anti-inflammatory and analgesic activity, while the R enantiomer does not inhibit prostaglandin synthesis and displays only analgesic activity. 包装 Unit quantity: 20 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1285750 | USP | Flurbiprofen | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. 生化/生理作用 Fluibiprofen is a cyclooxygenase (COX) inhibitor, which is an enzyme responsible for the conversion of arachidonic acid to prostaglandin G2 (PGG2) and PGG2 to prostaglandin H2 (PGH2) in the prostaglandin synthesis pathway. This decreases the prostaglandins which cause inflammation, pain, swelling and fever. Flurbiprofen inhibits the activity of both COX-1 and -2. The S enantiomer inhibits prostaglandin synthesis and has both anti-inflammatory and analgesic activity, while the R enantiomer does not inhibit prostaglandin synthesis and displays only analgesic activity. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PHR1499 | Supelco | Flurbiprofen | Pharmaceutical Secondary Standard; Certified Reference Material | 1085.85元/500 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. 应用 These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. 生化/生理作用 Fluibiprofen is a cyclooxygenase (COX) inhibitor, which is an enzyme responsible for the conversion of arachidonic acid to prostaglandin G2 (PGG2) and PGG2 to prostaglandin H2 (PGH2) in the prostaglandin synthesis pathway. This decreases the prostaglandins which cause inflammation, pain, swelling and fever. Flurbiprofen inhibits the activity of both COX-1 and -2. The S enantiomer inhibits prostaglandin synthesis and has both anti-inflammatory and analgesic activity, while the R enantiomer does not inhibit prostaglandin synthesis and displays only analgesic activity. 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAA3047 in the slot below. This is an example certificate only and may not be the lot that you receive. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 463477 | Fluorochem | Flurbiprofen | 95% | 418元/1g; 1232元/5g; 2398元/10g; 3630元/25g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||